Cannabis Use Disorder and Depression: A Bidirectional Link
The bidirectional relationship cannabis use disorder depression highlights the complex interplay between these conditions. Clinicians must screen for both disorders to provide integrated care. Understanding this link improves treatment outcomes for…
New study reveals surprising benefit of GLP-1s beyond weight loss
A recent study highlights the potential of GLP-1 addiction risk reduction in lowering vulnerability to multiple substances. This research suggests GLP-1 receptor agonists may influence reward pathways independently of weight loss. Clinicians should…
Smoking Cannabis May Reduce Alcohol Cravings, New Study Finds – Food & Wine
Cannabis alcohol cravings research suggests cannabis use may reduce alcohol cravings in some patients. This emerging evidence highlights potential harm reduction strategies for alcohol use disorder. Clinicians should carefully assess risks and benefits…
Popular Weight-Loss Drugs May Also Treat Addiction – SciTechDaily
GLP-1 receptor agonist addiction research suggests these drugs may reduce substance use disorders while aiding weight loss. This dual benefit offers promising clinical implications. However, further trials are needed to confirm these findings.
Weight Loss Drugs and Addiction Risk: New Insights from GLP-1 Research
GLP-1 receptor agonist addiction risk reduction is an emerging area of clinical interest. These medications may reduce addiction risk across multiple substances while managing weight. This dual potential could improve outcomes for patients with obesity…
Popular Diabetes Drugs May Help Combat Multiple Addictions, Major Study Shows
Recent research highlights glp-1 receptor agonists addiction benefits in reducing addictive behaviors across substances including cannabis. These diabetes medications show promise for patients with comorbid diabetes and substance use disorders.…
Kids as Young as 11 Being Treated for Cannabis Use Disorder, Children’s National Hospital Says
Cannabis use disorder in children is an emerging concern requiring early screening and intervention. Children as young as 11 are being treated for this disorder. Understanding youth cannabis accessibility helps inform prevention strategies.
GLP-1 Medications Get at the Heart of Addiction, Study Finds
GLP-1 medications addiction treatment shows promise in reducing cannabis use disorder alongside other substance use disorders. These medications may address multiple addiction pathways simultaneously rather than targeting individual substances.…
What to Know About How GLP-1 Medications Might Fight Addiction – The Washington Post
GLP-1 receptor agonist addiction treatment shows promise as a novel approach for substance use disorders. These medications, already used for metabolic diseases, may reduce cravings by affecting brain reward pathways. Ongoing research is crucial to…